These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 23921081

  • 1. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review.
    Idée JM, Guiu B.
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):530-49. PubMed ID: 23921081
    [Abstract] [Full Text] [Related]

  • 2. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Imai N, Ikeda K, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H.
    Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
    [Abstract] [Full Text] [Related]

  • 3. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.
    Koizumi Y, Hirooka M, Uehara T, Kisaka Y, Uesugi K, Kumagi T, Abe M, Matsuura B, Hiasa Y, Onji M.
    Hepatogastroenterology; 2011 Mar; 58(106):512-5. PubMed ID: 21661422
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
    Park YS, Lee CH, Kim JH, Kim IS, Kiefer B, Seo TS, Kim KA, Park CM.
    Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and literature review.
    Naorungroj T, Naksanguan T, Chinthammitr Y.
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S270-5. PubMed ID: 23590054
    [Abstract] [Full Text] [Related]

  • 7. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.
    Ikeda M, Arai Y, Park SJ, Takeuchi Y, Anai H, Kim JK, Inaba Y, Aramaki T, Kwon SH, Yamamoto S, Okusaka T, Japan Interventional Radiology in Oncology Study Group (JIVROSG), Korea Interventional Radiology in Oncology Study Group (KIVROSG).
    J Vasc Interv Radiol; 2013 Apr; 24(4):490-500. PubMed ID: 23466316
    [Abstract] [Full Text] [Related]

  • 8. Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
    Matsumoto T, Ichikawa H, Imai J, Hayashi T, Tomita K, Mine T, Kojima S, Watanabe N, Hasebe T.
    Anticancer Res; 2017 Jun; 37(6):3183-3187. PubMed ID: 28551662
    [Abstract] [Full Text] [Related]

  • 9. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
    Nishikawa H, Kita R, Kimura T, Osaki Y.
    Anticancer Res; 2014 Dec; 34(12):6877-86. PubMed ID: 25503113
    [Abstract] [Full Text] [Related]

  • 10. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.
    Irie T, Kuramochi M, Takahashi N.
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):706-13. PubMed ID: 22996589
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma.
    Takaki S, Sakaguchi H, Anai H, Tanaka T, Yamamoto K, Morimoto K, Nishiofuku H, Inoue M, Sueyoshi S, Nagata T, Hidaka T, Uchida H, Kichikawa K.
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):544-54. PubMed ID: 21739345
    [Abstract] [Full Text] [Related]

  • 12. Cerebral lipiodol embolism following abdomen trauma in a patient with hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Nie Q, Wu H, Guo P, Ge J, Qiu Y.
    Acta Neurol Belg; 2015 Sep; 115(3):459-61. PubMed ID: 25319130
    [No Abstract] [Full Text] [Related]

  • 13. Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.
    Woo HY, Heo J.
    Clin Mol Hepatol; 2015 Dec; 21(4):344-8. PubMed ID: 26770921
    [Abstract] [Full Text] [Related]

  • 14. Nitroglycerine use in transcatheter arterial (chemo)embolization in patients with hepatocellular carcinoma and dual-energy CT assessment of Lipiodol retention.
    Liu YS, Chuang MT, Tsai YS, Tsai HM, Lin XZ.
    Eur Radiol; 2012 Oct; 22(10):2193-200. PubMed ID: 22618520
    [Abstract] [Full Text] [Related]

  • 15. Cerebral lipiodol embolism after transarterial chemoembolization for hepatic carcinoma: a case report.
    Jia ZZ, Tian F, Jiang GM.
    World J Gastroenterol; 2012 Aug 14; 18(30):4069-70. PubMed ID: 22912560
    [Abstract] [Full Text] [Related]

  • 16. Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience.
    Favelier S, Boulin M, Hamza S, Cercueil JP, Cherblanc V, Lepage C, Hillon P, Chauffert B, Krausé D, Guiu B.
    Cardiovasc Intervent Radiol; 2013 Aug 14; 36(4):1039-46. PubMed ID: 23224215
    [Abstract] [Full Text] [Related]

  • 17. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
    Imai N, Ikeda K, Seko Y, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H.
    Oncology; 2011 Aug 14; 80(3-4):188-94. PubMed ID: 21709428
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma.
    Okimoto K, Ogasawara S, Chiba T, Ooka Y, Oobu M, Azemoto R, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Yoshikawa M, Yokosuka O.
    Anticancer Res; 2013 Dec 14; 33(12):5603-9. PubMed ID: 24324105
    [Abstract] [Full Text] [Related]

  • 19. Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin.
    Boulin M, Schmitt A, Delhom E, Cercueil JP, Wendremaire M, Imbs DC, Fohlen A, Panaro F, Herrero A, Denys A, Guiu B.
    Eur Radiol; 2016 Feb 14; 26(2):601-9. PubMed ID: 26060065
    [Abstract] [Full Text] [Related]

  • 20. Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day.
    Boulin M, Delhom E, Pierredon-Foulongne MA, Cercueil JP, Guiu B.
    Diagn Interv Imaging; 2015 Jun 14; 96(6):607-15. PubMed ID: 25998996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.